ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015

Oct 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-10-13

Reporting Person: Phillips Gary M. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-13	Stock Options (Right to Buy)	$9.50	A	24000	Acquired	2025-10-12	Common Stock (24000)	Direct

Footnotes

F1: This stock option award was issued pursuant to Issuer's 2014 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on October 13, 2016 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter so long as the Reporting Person is director of the Company on such date.